Arrowhead Pharmaceuticals, Inc. (ARWR)
64.19
-0.60
(-0.93%)
USD |
NASDAQ |
Oct 02, 16:00
64.06
-0.13
(-0.20%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Gross Profit Margin (Quarterly) : 91.15% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 91.15% |
| March 31, 2026 | 91.36% |
| December 31, 2025 | 97.58% |
| September 30, 2025 | 97.51% |
| June 30, 2025 | 77.59% |
| March 31, 2025 | 98.88% |
| December 31, 2024 | -109.4% |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | -20.05% |
| September 30, 2023 | 76.03% |
| June 30, 2023 | 79.30% |
| March 31, 2023 | 98.17% |
| December 31, 2022 | 95.70% |
| September 30, 2022 | 91.58% |
| June 30, 2022 | 91.97% |
| March 31, 2022 | 98.30% |
| December 31, 2021 | 90.62% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 60.18% |
| Moderna, Inc. | -7.59% |
| Revolution Medicines, Inc. | -- |
| Intellia Therapeutics, Inc. | 72.58% |
| Denali Therapeutics, Inc. | -52.39% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.33% |
| Return on Assets | -15.43% |
| Return on Invested Capital | -18.06% |
| Profit Margin (Quarterly) | -237.8% |
| Operating Margin (Quarterly) | -226.0% |
| Return on Net Operating Assets | -54.00% |